Verastem Oncology
VSTM
#7354
Rank
A$0.66 B
Marketcap
A$8.88
Share price
1.15%
Change (1 day)
-4.49%
Change (1 year)

Market capitalization of Verastem Oncology (VSTM)

Market cap: A$0.66 Billion

As of February 2026 Verastem Oncology has a market cap of A$0.66 Billion. This makes Verastem Oncology the world's 7354th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Verastem Oncology from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.66 B-26.24%
2025A$0.90 B241.42%
2024A$0.26 B-12.07%
2023A$0.30 B142.95%
2022A$0.12 B-75.88%
2021A$0.51 B9.54%
2020A$0.47 B206.7%
2019A$0.15 B-56.44%
2018A$0.35 B77.13%
2017A$0.19 B245.75%
2016A$57.47 M-39.06%
2015A$94.31 M-69.02%
2014A$0.30 B-5.95%
2013A$0.32 B87.93%
2012A$0.17 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Verastem Oncology was reported to be:

A$0.58 Billion
by Nasdaq info icon info icon
A$0.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$216.18 B 32,235.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$32.12 B 4,704.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$152.35 B 22,688.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
A$16.18 M-97.58%๐Ÿ‡บ๐Ÿ‡ธ USA